CASP3 and cervical cancer: The fact that the combination treatment resulted in a significant reduction of cell viability, increased oxidative stress, loss of MMP and enhanced caspase-3/9 activity suggests that cervical cancer cells become more sensitive to lower doses of PdNPs, when treated with TSA.